EDA fibronectin in keloids create a vicious cycle of fibrotic tumor formation

Journal of Investigative Dermatology

Volumn 135, Issue 7, 2015, Pages 1714-1718

  Kelsh, Rhiannon M ^a   McKeown Longo, Paula J ^a   Clark, Richard A F ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; ECTODYSPLASIN A;

ALTERNATIVE RNA SPLICING; BINDING SITE; CARCINOGENESIS; EMBRYO DEVELOPMENT; EXTRA DOMAIN A; EXTRACELLULAR MATRIX; HUMAN; HYPERTROPHIC SCAR; KELOID; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; WOUND HEALING; CELL ACTIVATION; FEEDBACK SYSTEM; NOTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN FIBROSIS; ANIMAL; CYTOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS;

ANIMALS; ECTODYSPLASINS; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; KELOID;

EID: 84931091169     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.155     Document Type: Note

References (66)

1. Akhmetshina A, Palumbo K, Dees C, et al. (2012) Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 3:735
2. Andrews JP, Marttala J, Macarak E, et al. (2015) Keloid pathogenesis: potential role of cellular fibronectin with the EDA domain. J Invest Dermatol 135:1921-4
3. Arslan F, Smeets MB, Rien V, P W., et al. (2011) Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res 108:582-92
4. Babu M, Diegelmann R, Oliver N (1992) Keloid fibroblasts exhibit an altered response to TGF-beta. J Invest Dermatol 99:650-5
5. Balza E, Borsi L, Allemanni G, et al. (1988) Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 228: 42-4
6. Bettinger DA, Yager DR, Diegelmann RF, et al. (1996) The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 98:827-33
7. Bhattacharyya S, Kelley K, Melichian DS, et al. (2013) Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol 182: 192-205
8. Bhattacharyya S, Tamaki Z, Wang W, et al. (2014) FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci Transl Med 6:232ra50
9. Blaustein M, Pelisch F, Coso OA, et al. (2004) Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J Biol Chem 279:21029-37
10. Bolognia JL, Jorizzo JL, Schaffer JV (2012) Dermatology 3rd (edn). Elsevier
11. Booth AJ, Wood SC, Cornett AM, et al. (2012) Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis. J Pathol 226: 609-18
12. Borsi L, Castellani P, Risso AM, et al. (1990) Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett 261:175-8
13. Buratti E, Baralle FE (2004) Influence of RNA secondary structure on the pre-mRNA splicing process. Mol Cell Biol 24:10505-4
14. Campaner AB, Ferreira LM, Gradnani A, et al. (2006) Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol 126: 1168-76
15. Chodon T, Sugihara T, Igawa HH, et al. (2000) Keloid-derived fibroblasts are refractory to Fasmediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol 157: 1661-9
16. Clark RAF (2014) Wound repair: basic biology to tissue engineering. In: Lanza RP, Langer RC, Vacanti JP (eds). Principles of Tissue Engineering, 4th edn. Elsevier: Amsterdam, Boston
17. Colwell AS, Phan TT, Kong W, et al. (2005) Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation. Plast Reconstr Surg 116:1387-90
18. Cramer P, Pesce CG, Baralle FE, et al. (1997) Functional association between promoter structure and transcript alternative splicing. Proc Natl Acad Sci USA 94:11456-60
19. Deno DC, Saba TM, Lewis EP (1983) Kinetics of endogenously labeled plasma fibronectin: incorporation into tissues. Am J Physiol 245: R564-75
20. Desmouliere A, Geinoz A, Gabbiani F, et al. (1993) Transforming growth factor-beta1 induces a-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-1
21. Ehrlich HP, Desmouliere A, Diegelmann RF, et al. (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105-3
22. Ffrench-Constant C, Van De Water L, Dvorak HF, et al. (1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109: 903-14
23. Gondokaryono SP, Ushio H, Niyonsaba F, et al. (2007) The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukocyte Biol 82:657-65
24. Greiling D, Clark RAF (1997) Fibronectin provides a conduit for fibroblast transmigration from a collagen gel into a fibrin gel. J Cell Sci 110: 861-70
25. Gurtner GC, Dauskardt RH, Wong VW, et al. (2011) Improving cutaneous scar formation by controlling the mechanical environment: large animal and phase I studies. Ann Surg 254: 217-5
26. Huebener P, Schwabe RF (2013) Regulation of woun dhealing and organ fibrosis by toll-like receptors. Biochim Biophys Acta 1832:1005-7
27. Inoue T, Nabeshima K, Shimao Y, et al. (1999) Hepatocyte growth factor/scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-β1 on fibronectin splicing at the EDA region. Biochem Biophys Res Commun 260:225-31
28. Kelsh R, You R, Horzempa C, et al. (2014) Regulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domains. PLoS One 9:e102974
29. Kohan M, Muro AF, Bader R, et al. (2011) The extra domain A of fibronectin is essential for allergen-induced airway fibrosis and hyperresponsiveness in mice. J Allergy Clin Immunol 127:439-6
30. Kohan M, Muro AF, White ES, et al. (2010) EDAcontaining cellular fibronectin induces fibroblast differentiation through binding to α4β7 integrin receptor and MAPK/Erk 1/2-dependent signaling. FASEB J 24:4503-12
31. Lasarte J, Casares N, GorraizM, et al. (2007) The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol 178:748-56
32. Lavigueur A, La Branche H, Kornblihtt AR, et al. (1993) A splicing enhancer in the human fibronectin alternatve ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev 7:2405-17
33. Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18: 816-27
34. Liao YF, Gotwals PJ, Koteliansky VE, et al. (2002) The EIIIA segment of fibronectin is a ligand for integrins alpha9beta1 and alpha4beta1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem 277:14467-74
35. Magnuson VL, Young M, Schattenberg DG, et al. (1991) The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J Biol Chem 266: 14654-62
36. McFadden JP, Basketter DA, Dearman RJ, et al. (2011) Extra domain A-positive fibronectinpositive feedback loops and their association with cutaneous inflammatory disease. Clin Dermatol 29:257-65
37. Mermoud JE, Cohen PT, Lamond AI (1994) Regulation of mammalian spliceosome assembly a protein phosphorylation mechanism. EMBO J 13:5679-88
38. Muro AF, Moretti FA, Moore BB, et al. (2008) An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 177:638-45
39. Naro C, Sette C (2013) Phosphorylation-mediated regulation of alternative splicing in cancer. Int J Cell Biol 2013:Article ID 151839-http://dx. doi.org/10.1155/2013/151839
40. Okamura KY, Watari M, Jerud ES, et al. (2002) The extra domain A of fibronectin activates Tolllike receptor 4. J Biol Chem 276:10229-33
41. Oyama F, Murata Y, Suganuma N, et al. (1989) Patterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues. Biochemistry 28:1428-34
42. Pagani F, Zagato L, Vergani C, et al. (1991) Tissuespecific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J Cell Biol 113:1223-9
43. Peters JH, Grote MN, Lane NE, et al. (2011) Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically-ill patients. Biomark Insights 6:59-68
44. Peters JH, Maunder RJ, Woolf AD, et al. (1989) Elevated plasma levels of ED1+ (cellular) fibronectin in patients with vascular injury. J Lab Clin Med 113:586-97
45. Petersen TE, Thogersen HC, Skorstengaard K, et al. (1983) Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc Natl Acad Sci USA 80: 137-41
46. Russell SB, Trupin KM, Rodriguez-Eaton S, et al. (1988) Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 85: 587-91
47. Satoi S, Kitade H, Hiramatsu Y, et al. (2000) Increased extra domain-A containing fibronectin and hepatic dysfunction during septic response: an in vivo and in vitro study. Shock 13:492-6
48. Schwarzbauer JE, DeSimone DW (2011) Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harbor Perspect Biol 3:A005041
49. Seebacher T, Manske M, Kornblihtt AR, et al. (1988) Cellular fibronectin is induced by epidermal growth factor, but not by dexamethasone or cyclic AMP in rat liver epithelial cells. FEBS Lett 239:113-6
50. Serini G, Bochaton-Piallat ML, Ropraz P, et al. (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142:873-1
51. Shinde AV, Bystroff C, Wang C, et al. (2008) Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin a9b1-dependent cellular activities. J Biol Chem 283:2858-70
52. Shinde AV, Kelsh R, Peters JH, et al. (2015) The alpha4beta1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts. Matrix Biol 41: 26-35
53. Singh P, Reimer CL, Peters JH, et al. (2004) The spatial and temporal expression patterns of integrin alpha9beta1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing. J Invest Dermatol 123: 1176-81
54. Srebrow A, Blaustein M, Kornblihtt AR (2002) Regulation of fibronectin alternative splicing by a basement membrane-like extracellular matrix. FEBS Lett 514:285-9
55. Sun XJ, Fa PP, Cui ZW, et al. (2014) The EDAcontaining cellular fibronectin induces epithelial mesenchymal transition in lung cancer cells through integrin a9b1-mediated activation of PI3-K/AKT and Erk1/2. Carcinogenesis 35:184
56. Tan MH, Sun Z, Opitz SL, et al. (2004) Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 104:11-8
57. van der Straaten HM, Canninga-van Dijk MR, Verdonck LF, et al. (2004) Extra-domain-A fibronectin: a new marker of fibrosis in cutaneous graft-versus-host defense. J Invest Dermatol 123:1057-62
58. Vartio T, Laitinen L, Narvanen O, et al. (1987) Differential expression of the ED sequencecontaining form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 88:419-30
59. Viedt C, Burger A, Hansch GM (1995) Fibronectin synthesis in tubular epithelial cells: up-regulation of the EDA splice variant by transforming growth factor beta. Kidney Int 48:1810-7
60. Vyalov SL, Gabbiani G, Kapanci Y (1993) Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycininduced pulmonary fibrosis. Am J Pathol 143: 1754-65
61. Welch MP, Odland GF, Clark RAF (1990) Temporal relationships of F-Actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 110:133-45
62. White ES, Sagana RL, Booth AJ, et al. (2010) Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway. Exp Cell Res 316:2644-53
63. Xia W, Phan TT, Lim IJ, et al. (2004) Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen 12: 546-6
64. Yamada KM, Clark RAF (1996) Provisional matrixIn: Molecular and Cellular Biology of Wound Repair Clark RAF ed 2nd (edn). Plenum: New York New York 51-93
65. Zhu J, Clark RA (2014) Fibronectin at select sites binds multiple growth factors and enhances their activity: expansion of the collaborative ECM-GF paradigm. J Invest Dermatol 134: 895-901
66. Zoppi N, Ritelli M, Colombi M (2012) Type III and V collagens modulate the expression and assembly of EDA+fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts. Biochim et Biophys Acta 1820:1576-87